Why Cell & Gene Operating Models Need To Be As Innovative As Your Science

By Omkar Kawalekar, Rohan Gupta, and Amit Agarwal

In the early stages of a cell and gene therapy (CGT) company’s evolution, the operating model is all about hiring and retaining key scientific/technical talent. Secondarily, it focuses on building an organizational structure that supports nimble decision-making by a small cohort of executives. Most early-stage CGT companies do not need or want a structured operating model that adds bureaucratic barriers and slows down the critical proof-of-concept achievement.